Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option

11) Department of Dermatology, Galliera Hospital, Genoa, Italy. 2) Department of Environmental Dermatology and Venereology, Medical University of Graz, giovanna.brunasso@gmail.com, Austria

2Department of Gastroenterology, Galliera Hospital, Italy

3Department of Dermatology, Medical University of Florence, Italy

4Department of Dermatology, Medical University of Graz, Austria

Hepatitis Monthly:Vol. 12, issue 5; 349-352

Published online:May 31, 2012

Article type:Case Report

Received:Apr 20, 2011

Accepted:May 12, 2012

How to Cite:Giovanna Brunasso A M, Michetti P, Fancelli L, Massone C. Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option.Hepat Mon.2012;12(5):349-352.https://doi.org/10.5812/hepatmon.6057.

Abstract

Background: Treatment of psoriasis in the setting of chronic hepatitis C virus (HCV) infection is diffcult, because standard therapies like methotrexate are associated with increased hepatic toxicity. Due to the HCV suppressive effect. Cyclosporine may represent a valid systemic alternative for psoriatic-HCV patients.
Objectives: In this study, we report the successful usage of intermittent cycles of cyclosporine in the setting of chronic HCV infection and we try to call the attention once again in a very effective and forgotten therapeutic option for severe chronic plaque psoriasis.
Observation: We describe a 48 years - old patient who has a 20 year history of severe chronic plaque psoriasis and HCV infection (aminotransferase levels are three times normal; HCV genotype 2a-2c and HCV-RNA titer of 2.050.000 UI-ml). Five courses (range of duration of three to six months) of oral cyclosporine (5 mg/kg/day) were followed during a 38 month period. The viral load and the transaminases’ levels diminished during the 38 months of intermittent cyclosporine therapy to the lowest level measured at 36th month. The good psoriatic response was associated to a slight improvement of the liver condition, even though the HCV-RNA was reduced by less than 1 log10 without normalization of aminotransferase’ levels.
Conclusions: The reduced liver toxicity, the potential anti-HCV properties and the well-known systemic anti-in?ammatory effect, make cyclosporine a good alternative for recalcitrant psoriatic patients with HCV-liver disease.

Implication for health policy/practice/research/medical education:
Cyclosporine can be considered a valid option for treatment of severe psoriasis in the setting of chronic HCV infection.
Please cite this paper as:
Giovanna Brunasso AM, Michetti P, Fancelli L, Massone C. Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option. Hepat Mon. 2012;12(5): 349-52. DOI: 10.5812/hepatmon.6057

Keywords

Psoriasis

Cyclosporine

Infection

Full Text

Full text is available in PDF

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 3
Last Update: 1 month ago
Scopus by Title: 3
Last Update: 1 month ago
Scopus by Title (Ref): 0
Last Update: 1 month ago
CrossRef: 2
Last Update: 6 days ago

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Alexandra Giovanna Brunasso:[PubMed][Scholar]
Paolo Michetti:[PubMed][Scholar]
Laura Fancelli:[PubMed][Scholar]
Cesare Massone:[PubMed][Scholar]

Official Journal of Research Center for Gastroenterology and Liver Diseases

Outlines

Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option

Abstract

Full Text

Crossmark

Checking

Last Update: 1 month ago

Last Update: 1 month ago

Last Update: 1 month ago

Last Update: 6 days ago